-
Join 669 other subscribers
-
Recent Posts
- DC dismissal of IPR institution decision action affirmed, reversed as to Apple’s improper USPTO rule-making argument
- Board finding of no obviousness reversed under “known-technique” motivation to combine rationale
- Board finding of no written description of genus claims in priority applications and anticipation affirmed
- IPR decision of no obviousness vacated and remanded for “fundamental legal error in defining the combination it was evaluating”
- DC order for Jazz to delist “computer-implemented system” claims from Orange Book affirmed
Recent Comments
Categories
- America Invents Act
- Analgous Art
- Anticipation (35 USC 102)
- Antitrust
- Appeal
- Arbitration
- Article III disputes
- Assignment / Ownership
- Attorney's Fees
- Bankruptcy
- Best mode
- Biosimilars
- Business methods
- Certificate of Correction
- Claim
- Claim Construction
- Claim Differentiation
- Claim Preclusion
- Claim Vitiation
- Collateral estoppel
- comprising
- Conception and Reduction to Practice
- consisting of
- Contributory Infringement
- Copyright
- Covered Business Method Reviews
- Damages
- Derivation of Invention
- Design Patents
- Diligence
- Disclaimers
- Discovery
- Doctrine of equivalents
- Double Patenting
- Enablement
- Equitable estoppel
- Exhaustion and Repair
- Experimental Use
- Expert Testimony
- Extension (156)
- False Marking
- Functional limitations
- Generics / ANDA
- Importation
- Incorporation by Reference
- Indefiniteness
- Inducement to Infringe
- Inequitable Conduct
- Infringement
- Inherency
- Injunction
- Inter Parties Review (IPR)
- Interference
- International Trade Commission
- Intervening Rights
- Inventorship
- IPR
- Issue Preclusion
- Jurisdiction
- Laches
- Licensing
- Lost Profits
- Malpractice
- Markush
- Means-plus-function
- Medical Devices
- Method claims
- Negative Limitations
- Obviousness
- Obviousness (Secondary Considerations)
- Obviousness-Teaching Away
- On-Sale Bar
- Patent Eligibility (101)
- Patent Exhaustion
- Patent Marking
- Patent Prosecution
- Patent Term Adjustment (PTA)
- Patent Term Extension
- Patentability
- Post-grant review
- Preamble
- Priority
- Privilege
- Procedural Issues
- Product-by-Process
- Prosecution History Estoppel
- Public Accessibility
- Public Use
- Reexamination
- Reissue
- Royalties
- Safe Harbor, FDA exemptions (271(e)(1))
- Section 101 (see also Patentability)
- Software
- State Sovereignty
- Summary Judgment
- Terminal Disclaimers
- Trade Dress
- Trade Secret
- Trademarks
- U.S. Supreme Court
- Uncategorized
- Unenforceability
- Unjust enrichment
- Utility
- Venue
- Wherein
- Willfullness
- Written description
Archives
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- July 2011
- February 2011
- January 2011
Meta
- Anticipation (35 USC 102) Appeal Article III disputes Assignment / Ownership Attorney's Fees Claim Construction Claim Differentiation Damages Doctrine of equivalents Enablement Generics / ANDA Indefiniteness Inducement to Infringe Infringement Inter Parties Review (IPR) Inventorship IPR Licensing Means-plus-function Obviousness Obviousness-Teaching Away Patentability Prosecution History Estoppel Reexamination Royalties Software Trademarks Uncategorized Willfullness Written description
Copyright Notice
© Patrick J. Halloran, Ph.D., J.D. and lifescienceip.wordpress.com, [2011-2017]. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Patrick J. Halloran, Ph.D., J.D. and lifescienceip.wordpress.com with appropriate and specific direction to the original content.
Monthly Archives: August 2017
Return Mail, Inc. v. United States Postal Service
Docket No. 2016-1502 (CBM2014-00116) PROST, NEWMAN (D), WALLACH August 28, 2017 Brief summary: Board decision that USPS had standing to pursue CBM challenge and finding certain claims patent ineligible under § 101 affirmed. Summary: Return Mail (RM) appealed PTAB decision … Continue reading
Ultratec, Inc. v. CaptionCall, LLC
Docket No. 2016-1706-10, -1712, 1715 (IPR2013-00540, -00541-45, -00550) NEWMAN, LINN, MOORE August 28, 2017 Brief summary: Board found to have “abused its discretion when it refused to admit and consider [the expert’s] trial testimony and…refused to explain its decision.” Summary: … Continue reading
Posted in Inter Parties Review (IPR), IPR
Leave a comment
In re: David Walter
Docket No. 2016-2256 MOORE, SCHALL, O’MALLEY August 21, 2017 Non-precedential Brief summary: Board decision on indefiniteness of the term “block-like” affirmed because, e.g., it “is a term of degree, without objective criteria in the patent’s intrinsic record for establishing the … Continue reading
Posted in Indefiniteness, Reexamination
Leave a comment
In re: Stepan Company
Docket No. 2016-1811 LOURIE (D), MOORE, O’MALLEY August 25, 2017 Brief summary: Board affirmance of examiner’s rejection of Stepan’s claims as obvious vacated and remanded because, e.g., “[t]he Board failed to explain why it would have been ‘routine optimization’”. Summary: … Continue reading
Posted in Obviousness
Leave a comment
Georgetown Rail Equipment Company v. Holland L.P.
Docket No. 2016-2297 REYNA, SCHALL, WALLACH August 16, 2017 Brief summary: DC’s infringement ($1.5m awarded), claim construction (preamble is not a limitation), willfulness, and enhanced damages ($1m) conclusions affirmed. Summary: Holland appealed the DC’s infringement ($1.5m awarded), claim construction, willfulness, … Continue reading
Posted in Claim Construction, Damages, Preamble, Willfullness
Leave a comment
Visual Memory LLC v. NVIDIA Corporation
Docket No. 2016-2254 O’MALLEY, HUGHES (D), STOLL August 15, 2017 Brief summary: DC finding that VM’s US 5,953,740 relating to computer memory systems was directed to ineligible subject matter reversed. Summary: Visual Memory (VM) appealed DC dismissal of VM’s infringement … Continue reading
Posted in Patentability
Leave a comment
Personal Audio, LLC v. Electronic Frontier Foundation
Docket No. 2016-1123 (IPR2014-00070) NEWMAN, CLEVENGER, O’MALLEY August 7, 2017 Brief summary: PTAB decision that Personal Audio’s ‘504 claims were anticipated and/or obvious affirmed. EFF found to have standing to defend PTAB decision since Personal Audio was appellant and the … Continue reading
AIA America, Inc. et al. v. Avid Raiopharmaceuticals / U. Penn.
Docket No. 2016-2647 NEWMAN, LOURIE, HUGHES August 10, 2017 Brief summary: DC decision was affirmed because “there is no right to a jury trial for attorney’s fees under § 285”. Summary: AIA appealed DC award of § 285 attorney’s fees … Continue reading
Posted in Attorney's Fees
Leave a comment
Amgen, Inc. et al. v. Hospira, Inc.
Docket No. 2016-2179 DYK, BRYSON, CHEN August 10, 2017 Brief summary: Amgens’s appeal for lack of jurisdiction and petition for a writ of mandamus dismissed and denied, respectively, since DC denial of Amgen’s motion to compel discovery is “reviewable from … Continue reading
Posted in Biosimilars, Generics / ANDA
Leave a comment
Homeland Housewares, LLC v. Whirlpool Corporation
Docket No. 2016-1511 (IPR2014-00877) PROST, NEWMAN, DYK August 4, 2017 Brief summary: Board decision of no anticipation of Whirlpool’s patent related to blenders reversed based on analysis after claim construction. Summary: Homeland appealed Board IPR decision that Whirlpool’s US 7,581,688 … Continue reading